Loading…

Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses

A synthetic chimeric gene, TBI-HBS, encoding the immunogenic ENV and GAG epitopes of human immunodeficiency virus (HIV-1) and the surface protein antigen (HBsAg) of hepatitis B virus (HBV), was expressed in tomato plants. Tomato fruits containing the TBI-HBS antigen were fed to experimental mice and...

Full description

Saved in:
Bibliographic Details
Published in:Biotechnology letters 2006-07, Vol.28 (13), p.959-967
Main Authors: Shchelkunov, Sergei N, Salyaev, Rurik K, Pozdnyakov, Sergei G, Rekoslavskaya, Natalia I, Nesterov, Andrei E, Ryzhova, Tatiana S, Sumtsova, Valentina M, Pakova, Natalia V, Mishutina, Uliana O, Kopytina, Tatiana V, Hammond, Rosemarie W
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A synthetic chimeric gene, TBI-HBS, encoding the immunogenic ENV and GAG epitopes of human immunodeficiency virus (HIV-1) and the surface protein antigen (HBsAg) of hepatitis B virus (HBV), was expressed in tomato plants. Tomato fruits containing the TBI-HBS antigen were fed to experimental mice and, on days 14 and 28 post-feeding, high levels of HIV- and HBV-specific antibodies were present in the serum and feces of the test animals. Intraperitoneal injection of a DNA vaccine directing synthesis of the same TBI-HBsAg antigen boosted the antibody response to HIV in the blood serum; however, it had no effect on the high level of antibodies produced to HBV.
ISSN:0141-5492
1573-6776
DOI:10.1007/s10529-006-9028-4